A truncating mutation (C to T transition) at codon 531 of the human protooncogene c-src, possibly accounting for the activation of c-src tyrosine kinase, has been recently identified in a subset of advanced colorectal cancer from North-American patients. However, two subsequent studies have failed to confirm the occurrence of SRC 531 mutation in colorectal cancers from North-European and Asiatic patients, raising the hypothesis that the genetic activation of src in colon cancer might be restricted to patients belonging to specific ethnic groups. We investigated a large series of colorectal cancers from Italian patients (155 cases) with a high prevalence of liver metastasis (43%). Using a PCR-RFLP assay, the occurrence of a SRC 531 mutation was ruled out in all the investigated specimens of primary tumours and/or metastases. Our results demonstrate that SRC Gln531AMB plays no role in the development or in the progression of colorectal cancer among Italian patients.
Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients / Laghi, L; Bianchi, P; Orbetegli, O; Gennari, L; Roncalli, M; Malesci, A. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - 84:2(2001), pp. 196-198. [10.1054/bjoc.2000.1560]
|Appare nelle tipologie:||1.1 Articolo su rivista|